Picture of Enliven Therapeutics logo

ELVN — Enliven Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Imara Inc - On Sept 6, Co Entered Into An Asset Purchase Agreement With Cardurion Pharmaceuticals

Sept 7 (Reuters) - Imara Inc  IMRA.O :
    * IMARA INC - ON SEPT 6, CO ENTERED INTO AN ASSET PURCHASE
AGREEMENT WITH CARDURION PHARMACEUTICALS
    * IMARA INC - SALE OF TOVINONTRINE (IMR-687) AND ALL OTHER
ASSETS
OF COMPANY RELATED TO ITS PDE9 PROGRAM

Source text for Eikon:  ID:nFWN30D1JH 
Further company coverage:  IMRA.O 

 (Reporting by Pratik Jain)
 ((Pratik.Jain@thomsonreuters.com;))

Recent news on Enliven Therapeutics

See all news